Discover & Read Articles Without Distractions

Find and explore trending articles from around the web in a clutter-free reading mode.

Sign up for a free account and get the following:
  • Save articles and sync them across your devices
  • Get a digest of the latest premium articles in your inbox twice a week, personalized to you (Coming soon).
  • Get access to our AI features
  • Articles Tagged with "Pharmaceuticals"

    Alberta signed deal to import medication from Turkey despite recommendations against it - The Globe and Mail

    theglobeandmail.com • Politics • Canada

    Alberta's government controversially imported children's medication from Turkey despite expert warnings about potential financial losses, leading to investigations and legal disputes.

    Sanidad aparca la reforma del copago farmacĂŠutico y resucita las subastas de medicamentos

    elespanol.com • Healthcare • Spain

    Spain's Ministry of Health has unveiled a revised pharmaceutical law, postponing the pharmaceutical co-payment reform and introducing a new drug auction system to increase competition and lower costs.

    Health lobby spending surged at end of 2024

    axios.com • Politics • USA

    Increased lobbying spending by healthcare groups, including pharmaceutical companies, PBMs, and physician associations, preceded a crucial government funding deal in late 2024.

    Trump da el primer paso para imponer aranceles a los chips y los productos farmacéuticos | Internacional | EL PAÍS

    elpais.com • Politics • United States

    Donald Trump is initiating investigations into imposing tariffs on imported microprocessors and pharmaceuticals, citing national security concerns and aiming to boost domestic production.

    White House, Florida promote Canada drug imports while tariff threat looms - The Globe and Mail

    theglobeandmail.com • Politics • World

    The White House and Florida are promoting Canadian drug imports to lower costs, despite potential US tariffs on pharmaceuticals.

    Bristol Myers shares fall after a failed trial. This is our plan for the stock — for now

    cnbc.com • Finance • World

    Bristol Myers Squibb's stock falls after a failed schizophrenia drug trial, prompting a cautious approach from the CNBC Investing Club.

    Helvetia-Baloise-Fusion: Grätscht Zurich noch dazwischen?

    themarket.ch • Finance • Switzerland

    The proposed Helvetia-Baloise merger faces uncertainty, with Zurich Insurance potentially making a counter-offer, while other Swiss companies like Roche, Novartis, Galderma, and Schindler navigate market challenges.

    Litigators of the Week: A $406.8M Win for Regeneron in Antitrust Trial Showdown With Cholesterol Drug Rival Amgen

    law.com • Law • World

    A Delaware jury awarded Regeneron $406.8 million in its antitrust lawsuit against Amgen, alleging Amgen illegally bundled its cholesterol drug with others to exclude Regeneron's competitor.

    Estos son los 10 medicamentos mĂĄs recetados en la CCSS, ÂżquĂŠ lugar ocupa la crema de rosas? | La NaciĂłn

    nacion.com • Medicine • Costa Rica

    This article details the top 10 most prescribed medications in Costa Rica's Social Security System (CCSS) in 2024, highlighting their uses and implications for public health.

    Sanidad quiere poner cerco a los tranquilizantes: se toman en exceso y se cronifican | Sociedad | EL PAÍS

    elpais.com • Health • Spain

    Spain's Ministry of Health aims to curb the overuse of tranquilizers and antidepressants, addressing concerns about overprescription and the medicalization of everyday suffering.

    Suben a 34 los muertos por fentanilo clínico contaminado en Argentina | EL PAÍS Argentina

    elpais.com • Health • Argentina

    Contaminated fentanyl has caused the deaths of 34 people in Argentina, prompting investigations into the involved pharmaceutical companies and raising concerns about public health.

    Healthcare News: Todays Healthcare Industry News, Healthcare Sectors Updates | The Economic Times

    economictimes.indiatimes.com • Healthcare • India

    Eli Lilly's Mounjaro, a weight-loss and diabetes drug, has seen rapid sales growth in India, driven by young adults upgrading dosages, but experts raise concerns about long-term effects and affordability.

    Why NHS fat jab rollout won't solve UK obesity crisis - but YOU will still end up paying as yo-yo porkers get hooked | The Sun

    thesun.co.uk • Health • UK

    The article critiques the NHS's rollout of weight-loss injections, arguing that while effective, they don't address the root causes of obesity and may lead to a cycle of weight gain and loss.

    China closes biotech gap with US as new drugs, R&D pipelines top 30% of global total | South China Morning Post

    scmp.com • Biotech • China

    China's biotech sector is rapidly expanding, with new drug approvals and R&D pipelines exceeding 30% of the global total, significantly closing the gap with the US.